Name | 2-[2-fluoro-6-(methylamino)pyridin-3-yl]-1-benzofuran-5-ol |
---|---|
Synonyms |
unii-g5k506j69e
azd 4694 |
Description | AZD4694, a fluorinated β-amyloid (Aβ) plaque neuroimaging PET radioligand, shows high affinity for Aβ fibrils (Kd = 2.3 nM)[1]. |
---|---|
Related Catalog | |
Target |
Kd: 2.3 nM (Aβ) |
In Vivo | Administration of unlabeled AZD4694 to rat showed that it has a pharmacokinetic profile consistent with good PET radioligands, it quickly entered and rapidly cleared from normal rat brain tissue[1]. AZD4694 (4 mL/kg; intravenous injection) inhibits [3H]AZD2184 binding (1 nM) in a concentration-dependent manner, with a Ki of 23.1 nM, in postmortem brain sections from AD patients[1]. Animal Model: Male Sprague–Dawley rats (275-300 g)[1] Dosage: 4 mL/kg Administration: I.v. Result: Inhibited [3H]AZD2184 binding in a concentration-dependent manner, with a Ki of 23.1 nM, in postmortem brain sections from AD patients. |
References |
Molecular Formula | C14H11FN2O2 |
---|---|
Molecular Weight | 258.24800 |
Exact Mass | 258.08000 |
PSA | 61.52000 |
LogP | 2.80310 |
Precursor 3 | |
---|---|
DownStream 0 |